Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.1 USD | -1.20% |
|
-1.20% | +3.54% |
Sales 2024 * | 346M 253M | Sales 2025 * | 356M 261M | Capitalization | 576M 422M |
---|---|---|---|---|---|
Net income 2024 * | 2M 1.47M | Net income 2025 * | 13M 9.52M | EV / Sales 2024 * | 1.67 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.62 x |
P/E ratio 2024 * |
199
x | P/E ratio 2025 * |
55.8
x | Employees | 725 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.52% |
Latest transcript on Knight Therapeutics Inc.
1 day | -1.20% | ||
1 week | -1.20% | ||
Current month | -1.20% | ||
1 month | -1.91% | ||
3 months | +4.06% | ||
6 months | +0.34% | ||
Current year | +3.54% |
![Extreme 4.1](/images/extremecours_fleche.png)
![Extreme 3.96](/images/extremecours_fleche.png)
![Extreme 3.855](/images/extremecours_fleche.png)
![Extreme 3.201](/images/extremecours_fleche.png)
![Extreme 3.19](/images/extremecours_fleche.png)
![Extreme 3.19](/images/extremecours_fleche.png)
![Extreme 3.19](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Samira Sakhia
CEO | Chief Executive Officer | 55 | 13-10-31 |
Jonathan Goodman
FOU | Founder | 56 | 13-10-31 |
Arvind Utchanah
DFI | Director of Finance/CFO | - | 16-06-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Gale
BRD | Director/Board Member | 74 | 14-01-05 |
Jonathan Goodman
FOU | Founder | 56 | 13-10-31 |
Robert Lande
BRD | Director/Board Member | 61 | 12-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-02 | 4.1 | -1.20% | 9,600 |
Delayed Quote OTC Markets, July 02, 2024 at 09:30 am EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.90% | 71.83B | |
+22.78% | 9.56B | |
+30.09% | 4.85B | |
-21.31% | 4.48B | |
+24.78% | 3.9B | |
+11.03% | 2.01B | |
-2.11% | 1.99B | |
-36.28% | 1.89B | |
-43.19% | 1.77B |
- Stock Market
- Equities
- GUD Stock
- KHTRF Stock